Teacher Retirement System of Texas Has $807,000 Stock Holdings in Bath & Body Works, Inc. $BBWI

Teacher Retirement System of Texas decreased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 47.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 31,318 shares of the company’s stock after selling 28,615 shares during the period. Teacher Retirement System of Texas’ holdings in Bath & Body Works were worth $807,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of BBWI. JPMorgan Chase & Co. grew its position in Bath & Body Works by 11.5% in the second quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after acquiring an additional 733,000 shares during the last quarter. Alliancebernstein L.P. boosted its stake in shares of Bath & Body Works by 5.8% in the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after purchasing an additional 315,738 shares in the last quarter. Cooper Creek Partners Management LLC grew its holdings in shares of Bath & Body Works by 42.7% during the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after purchasing an additional 1,619,276 shares during the last quarter. AQR Capital Management LLC increased its position in Bath & Body Works by 5.3% during the 2nd quarter. AQR Capital Management LLC now owns 4,203,326 shares of the company’s stock worth $125,322,000 after purchasing an additional 210,153 shares in the last quarter. Finally, GMT Capital Corp lifted its stake in Bath & Body Works by 8.8% in the 2nd quarter. GMT Capital Corp now owns 4,067,000 shares of the company’s stock valued at $121,847,000 after purchasing an additional 329,300 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Francis Hondal purchased 3,343 shares of the business’s stock in a transaction on Friday, November 21st. The shares were acquired at an average price of $14.99 per share, with a total value of $50,111.57. Following the completion of the transaction, the director owned 21,554 shares of the company’s stock, valued at $323,094.46. The trade was a 18.36% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lucy Brady acquired 3,470 shares of the stock in a transaction dated Friday, November 21st. The stock was acquired at an average cost of $14.40 per share, with a total value of $49,968.00. Following the completion of the transaction, the director owned 17,482 shares in the company, valued at approximately $251,740.80. This represents a 24.76% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders have purchased 33,513 shares of company stock valued at $500,442. 0.27% of the stock is owned by corporate insiders.

Bath & Body Works Trading Down 0.9%

Shares of BBWI opened at $22.05 on Wednesday. The stock’s 50-day moving average price is $20.63 and its two-hundred day moving average price is $24.54. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $41.87. The company has a market capitalization of $4.51 billion, a PE ratio of 6.78, a PEG ratio of 0.98 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The company’s quarterly revenue was down 1.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Friday, November 21st were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date of this dividend was Friday, November 21st. Bath & Body Works’s dividend payout ratio is currently 24.62%.

Key Headlines Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Neutral Sentiment: Summary: The class period is June 4, 2024–November 19, 2025 and many firms cite a March 16, 2026 deadline for lead‑plaintiff filings; eligible purchasers may be contacted about contingency‑fee representation. ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bath & Body Works, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BBWI
• Negative Sentiment: Rosen Law Firm: reminded purchasers they may seek lead‑plaintiff status and compensation without upfront fees; emphasizes the March 16 deadline. ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Bath & Body Works, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BBWI
• Negative Sentiment: Schall Law Firm: filed/announced a securities fraud class action under Sections 10(b) and 20(a) alleging misleading statements and invites investors to contact the firm before March 16. BBWI Investors Have Opportunity to Lead Bath & Body Works, Inc. Securities Fraud Lawsuit with the Schall Law Firm
• Negative Sentiment: Pomerantz LLP: announced a class action and is soliciting investors who suffered losses during the class period to contact the firm. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bath & Body Works, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBWI
• Negative Sentiment: Bleichmar Fonti & Auld (BFA): alleges securities fraud tied to growth claims and stock drops, invites affected investors to contact the firm ahead of the March deadline. BATH & BODY STOCK NOTICE: Bath & Body Works, Inc. (BBWI) Accused of Misleading Investors in the Securities Fraud Class Action – Contact BFA Law by March 16 Court Deadline
• Negative Sentiment: Robbins LLP: issued a shareholder alert about the filed class action and urged investors to contact the firm about leading the case. Shareholder Rights Law Firm Robbins LLP Urges BBWI Investors to Contact the Firm About Leading the Class Action Against Bath & Body Works, Inc.
• Negative Sentiment: DJS Law Group / PR Newswire: announced a securities‑law suit and solicited shareholders who purchased during the class period. Bath & Body Works, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – BBWI
• Negative Sentiment: Bernstein Liebhard LLP: issued a shareholder alert reminding investors of the upcoming deadline and providing contact details for potential lead‑plaintiff inquiries. BATH & BODY WORKS, INC. (NYSE: BBWI) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Bath & Body Works, Inc. Investors of Upcoming Deadline

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on BBWI. UBS Group boosted their target price on shares of Bath & Body Works from $17.00 to $21.00 and gave the stock a “neutral” rating in a research note on Thursday, January 8th. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Deutsche Bank Aktiengesellschaft began coverage on Bath & Body Works in a report on Thursday, January 8th. They issued a “hold” rating and a $21.00 target price for the company. Morgan Stanley reissued an “equal weight” rating and set a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a research note on Friday, November 21st. Finally, Zacks Research upgraded Bath & Body Works from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 20th. Five research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $23.53.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.